-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ASY8NSbSutsVrFeBJD8/nVQCbpLkztpLMUXnGsL1xqOdMnXR0ws4cjjWRO9X69fo uGpUQ20hjGvSyOFtO9lNtA== 0000904454-06-000205.txt : 20060209 0000904454-06-000205.hdr.sgml : 20060209 20060209163155 ACCESSION NUMBER: 0000904454-06-000205 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060209 DATE AS OF CHANGE: 20060209 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0103 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 7325242454 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BARRIER THERAPEUTICS INC CENTRAL INDEX KEY: 0001173657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223828030 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79875 FILM NUMBER: 06593454 BUSINESS ADDRESS: STREET 1: 600 COLLEGE ROAD EAST STREET 2: SUITE 3200 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6099451200 SC 13G/A 1 s13ga_0208-2006barrier.txt AMENDMENT TO BARRIER THERAPEUTICS SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ----------------- SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1 )(1) Barrier Therapeutics, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.0001 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 06850R 10 8 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2005 ------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) - -------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. CUSIP No. 06850R 10 8 Page 2 of 7 Pages - -------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Johnson & Johnson 22-1024240 - -------------------------------- 2. CHECK THE APPROPRIATE BOX IF (a) [ ] A MEMBER OF A GROUP (b) [ ] - -------------------------------- 3. SEC USE ONLY - -------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION New Jersey - -------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES BENEFICIALLY -0- OWNED BY EACH 6. SHARED VOTING POWER REPORTING PERSON WITH 3,753,749 shares of Common Stock ------------------------------------------ 7. SOLE DISPOSITIVE POWER -0- ------------------------------------------ 8. SHARED DISPOSITIVE POWER 3,753,749 shares of Common Stock - -------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,753,749 shares of Common Stock - -------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 15.6% - -------------------------------- 12. TYPE OF REPORTING PERSON CO - -------------------------------- CUSIP No. 06850R 10 8 Page 3 of 7 Pages - -------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Johnson & Johnson Consumer Companies, Inc. - -------------------------------- 2. CHECK THE APPROPRIATE BOX IF (a) [ ] A MEMBER OF A GROUP (b) [ ] - -------------------------------- 3. SEC USE ONLY - -------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES BENEFICIALLY -0- OWNED BY EACH 6. SHARED VOTING POWER REPORTING PERSON WITH 856,028 shares of Common Stock ------------------------------------------ 7. SOLE DISPOSITIVE POWER -0- ------------------------------------------ 8. SHARED DISPOSITIVE POWER 856,028 shares of Common Stock - -------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 856.028 shares of Common Stock - -------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.6% - -------------------------------- 12. TYPE OF REPORTING PERSON CO - -------------------------------- CUSIP No. 06850R 10 8 Page 4 of 7 Pages - -------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Johnson & Johnson Development Corporation 22-2007137 - -------------------------------- 2. CHECK THE APPROPRIATE BOX IF (a) [ ] A MEMBER OF A GROUP (b) [ ] - -------------------------------- 3. SEC USE ONLY - -------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION New Jersey - -------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES BENEFICIALLY -0- OWNED BY EACH 6. SHARED VOTING POWER REPORTING PERSON WITH 256,410 shares of Common Stock ------------------------------------------ 7. SOLE DISPOSITIVE POWER -0- ------------------------------------------ 8. SHARED DISPOSITIVE POWER 256,410 shares of Common Stock - -------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 256,410 shares of Common Stock - -------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.1% - -------------------------------- 12. TYPE OF REPORTING PERSON CO - -------------------------------- CUSIP No. 06850R 10 8 Page 5 of 7 Pages - -------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Janssen L.P. - -------------------------------- 2. CHECK THE APPROPRIATE BOX IF (a) [ ] A MEMBER OF A GROUP (b) [ ] - -------------------------------- 3. SEC USE ONLY - -------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION New Jersey - -------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES BENEFICIALLY -0- OWNED BY EACH 6. SHARED VOTING POWER REPORTING PERSON WITH 2,641,311 shares of Common Stock ------------------------------------------ 7. SOLE DISPOSITIVE POWER -0- ------------------------------------------ 8. SHARED DISPOSITIVE POWER 2,641,311 shares of Common Stock - -------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,641,311 shares of Common Stock - -------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11.0% - -------------------------------- 12. TYPE OF REPORTING PERSON PN - -------------------------------- CUSIP No. 06850R 10 8 Page 6 of 7 Pages Amendment No. 1 to Schedule 13G Reference is hereby made to the statement on Schedule 13G originally filed with the Securities and Exchange Commission on February 8, 2005 (the "Schedule 13G".) Terms defined in the Schedule 13G are used herein as so defined. The following Items of the Schedule 13G are hereby amended and restated to read in their entirety as follows: ITEM 2(a) - NAME OF PERSON FILING: JPP has changed its name to Janssen L.P. ITEM 4 - OWNERSHIP: (a) Amount Beneficially Owned: J&J: 3,753,749 shares of Common Stock JJDC: 256,410 shares of Common Stock JPP: 2,641,311 shares of Common Stock JJCC: 856,028 shares of Common Stock (b) Percent of Class: J&J: 15.6% JJDC: 1.1% JPP: 11.0% JJCC: 3.6% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: -0- (ii) shared power to vote or to direct the vote: J&J: 3,753,749 shares of Common Stock JJDC: 256,410 shares of Common Stock JPP: 2,641,311 shares of Common Stock JJCC: 856,028 shares of Common Stock (iii) sole power to dispose or to direct the disposition of: -0- (iv) shared power to dispose or to direct the disposition of: J&J: 3,753,749 shares of Common Stock JJDC: 256,410 shares of Common Stock JPP: 2,641,311 shares of Common Stock JJCC: 856,028 shares of Common Stock CUSIP No. 06850R 10 8 Page 7 of 7 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. JOHNSON & JOHNSON By /s/ MICHAEL H. ULLMANN ---------------------------- Name: Michael H. Ullmann Title: Secretary JOHNSON & JOHNSON DEVELOPMENT CORPORATION By /s/ MANISH YADAV ---------------------------- Name: Manish Yadav Title: Secretary JANSSEN L.P. By Janssen Pharmaceutica, Inc., General Partner By /s/ MIKE C. CHESTER ---------------------------- Name: Mike C. Chester Title: Secretary JOHNSON & JOHNSON CONSUMER COMPANIES, INC. By /s/ DONNA M. MALIN ---------------------------- Name: Donna M. Malin Title: Secretary Dated: January 25, 2006 -----END PRIVACY-ENHANCED MESSAGE-----